Study Purpose:
The investigators want to know if magnetic resonance imaging can accurately provide an early diagnosis of amyotrophic lateral sclerosis (ALS).Study Status:
Not recruiting
Disease:
Amyotrophic Lateral Sclerosis
Study Type:
Interventional
Type of Intervention:
N/A
Intervention Name:
MRI, Clinical Exam
Placebo:
Phase:
N/A
Study Chair(s)/Principal Investigator(s):
Bradley Foerster, M.D., University of Michigan Hospital
Clinicaltrials.gov ID:
Neals Affiliated?
No
Coordinating Center Contact Information
University of Michigan
Ann Arbor, Michigan, 48109 United States
Full Study Summary:
Currently there is no definitive diagnostic test for amyotrophic lateral sclerosis (ALS). The investigators' goal is to determine if magnetic resonance imaging can provide an accurate diagnosis of ALS by looking at chemical concentrations in the spinal cord at the neck level which show up in MRI imaging and compare these chemical concentrations to corresponding measures in healthy control subjects.
Study Sponsor:
University of Michigan
Estimated Enrollment:
20
Estimated Study Start Date:
10 / 01 / 2013
Estimated Study Completion Date:
08 / 01 / 2015
Posting Last Modified Date:
06 / 04 / 2018
Date Study Added to neals.org:
12 / 04 / 2013
Minimum Age:
18 Years
Maximum Age:
80 Years
Inclusion Criteria:1. Adults age 18 to 80 years of age.
Exclusion Criteria:
1. Do not have active substance abuse
2. Do not have co-morbid psychiatric disease
3. Do not have opportunistic central nervous system infection
4. Do not have cerebrovascular disease
5. Do not have a contraindication for magnetic resonance imaging(MRI)(e.g. cardiac pacemaker, ferromagnetic or metallic implants).
6. Are not pregnant
7. Have not had cervical spinal surgery(neck) -
University of Michigan Hospital
Ann Arbor, Michigan
48109
United States